Education
About Us
Working with TipRanks
Follow Us
Gossamer Bio Inc (GOSS)
NASDAQ:GOSS
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 114.70M | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 114.70M | $ -4.38M | $ -4.43M | $ -5.17M | $ -4.27M |
| Operating Income | $ -59.92M | $ -183.76M | $ -218.59M | $ -216.12M | $ -233.96M |
| EBITDA | $ -39.97M | $ -172.15M | $ -211.07M | $ -209.32M | $ -233.96M |
| Net Income | $ -56.53M | $ -179.82M | $ -240.23M | $ -249.08M | $ -251.58M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 294.52M | $ 296.43M | $ 255.68M | $ 325.22M | $ 512.63M |
| Total Assets | $ 315.29M | $ 311.92M | $ 272.45M | $ 343.66M | $ 539.43M |
| Total Debt | $ 202.88M | $ 212.46M | $ 225.74M | $ 185.24M | $ 183.73M |
| Net Debt | $ 156.81M | $ 180.35M | $ 113.77M | $ 1.83M | $ -302.32M |
| Total Liabilities | $ 285.80M | $ 249.15M | $ 260.37M | $ 222.19M | $ 218.75M |
| Stockholders' Equity | $ 29.49M | $ 62.77M | $ -1.03B | $ -811.53M | $ -577.53M |
| Cash Flow | |||||
| Free Cash Flow | $ -3.47M | $ -159.16M | $ -187.51M | $ -190.51M | $ -201.24M |
| Operating Cash Flow | $ -3.47M | $ -159.16M | $ -187.03M | $ -188.89M | $ -176.36M |
| Investing Cash Flow | $ 29.02M | $ -110.97M | $ -1.03M | $ -117.43M | $ 215.34M |
| Financing Cash Flow | $ -11.49M | $ 190.15M | $ 117.09M | $ 3.33M | $ 312.54M |